KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Net Margin (2016 - 2024)

Novartis Ag's Net Margin history spans 13 years, with the latest figure at 30.7% for Q2 2024.

  • On a quarterly basis, Net Margin rose 3053.0% to 30.7% in Q2 2024 year-over-year; TTM through Jun 2024 was 12.12%, a 991.0% increase, with the full-year FY2025 number at 25.64%, up 191.0% from a year prior.
  • Net Margin hit 30.7% in Q2 2024 for Novartis Ag, up from 0.85% in the prior quarter.
  • Over the last five years, Net Margin for NVS hit a ceiling of 2028.51% in Q4 2020 and a floor of 0.17% in Q2 2023.
  • Historically, Net Margin has averaged 211.42% across 5 years, with a median of 51.95% in 2022.
  • Biggest five-year swings in Net Margin: surged 12415bps in 2020 and later plummeted -201434bps in 2021.
  • Tracing NVS's Net Margin over 5 years: stood at 2028.51% in 2020, then plummeted by -99bps to 14.17% in 2021, then surged by 320bps to 59.45% in 2022, then plummeted by -99bps to 0.85% in 2023, then surged by 3493bps to 30.7% in 2024.
  • Business Quant data shows Net Margin for NVS at 30.7% in Q2 2024, 0.85% in Q4 2023, and 0.17% in Q2 2023.